Glycogen Storage Disease Type 9
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Glycogen Storage Disease Type 9

What is the definition of Glycogen Storage Disease Type 9?

Glycogen storage disease type IX (also known as GSD IX) is a condition caused by the inability to break down a complex sugar called glycogen. The different forms of the condition can affect glycogen breakdown in liver cells or muscle cells or sometimes both. A lack of glycogen breakdown interferes with the normal function of the affected tissue.

What are the causes of Glycogen Storage Disease Type 9?

Mutations in the PHKA1, PHKA2, PHKB, or PHKG2 genes are known to cause GSD IX. These genes provide instructions for making pieces (subunits) of an enzyme called phosphorylase b kinase. The enzyme is made up of 16 subunits, four each of the alpha, beta, gamma, and delta subunits. At least two different versions of phosphorylase b kinase are formed from the subunits: one is most abundant in liver cells and the other in muscle cells.

How prevalent is Glycogen Storage Disease Type 9?

GSD IX that affects the liver is estimated to occur in 1 in 100,000 people. The forms of the disease that affect muscles or both muscles and liver are much less common, although the prevalence is unknown.

Is Glycogen Storage Disease Type 9 an inherited disorder?

GSD IX can have different inheritance patterns depending on the genetic cause of the condition.

Who are the top Glycogen Storage Disease Type 9 Local Doctors?
Elite in Glycogen Storage Disease Type 9
Elite in Glycogen Storage Disease Type 9

Duke Health Integrated Practice Inc

40 Duke Medicine Cir, 
Durham, NC 
Languages Spoken:
English
Accepting New Patients

Priya Kishnani is a Pediatrics provider practicing medicine in Durham, North Carolina. Dr. Kishnani is rated as an Elite provider by MediFind in the treatment of Glycogen Storage Disease Type 9. She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Pompe Disease, Glycogen Storage Disease Type 3, Hypophosphatasia (HPP), Glycogen Storage Disease Type 9, and Splenectomy. Dr. Kishnani is currently accepting new patients.

Distinguished in Glycogen Storage Disease Type 9
Distinguished in Glycogen Storage Disease Type 9

Neuromuscular Research Center

4545 E Shea Blvd, Ste 175, 
Phoenix, AZ 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Kumaraswamy Sivakumar is a Neurologist practicing medicine in Phoenix, Arizona. Dr. Sivakumar is rated as a Distinguished provider by MediFind in the treatment of Glycogen Storage Disease Type 9. He is also highly rated in 73 other conditions, according to our data. His clinical expertise encompasses Inclusion Body Myositis, Myasthenia Gravis, Chronic Inflammatory Demyelinating Polyneuropathy, and Pompe Disease. Dr. Sivakumar is board certified in Psychiatry & Neurology (Neurology), Psychiatry & Neurology (Sub: Clinical Neurophysiolog, and Psychiatry & Neurology (Sub: Neuromuscular Medicine). Dr. Sivakumar is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Distinguished in Glycogen Storage Disease Type 9
Distinguished in Glycogen Storage Disease Type 9
2701 Patriot Blvd, 
Glenview, IL 
Experience:
36+ years
Languages Spoken:
English
Offers Telehealth

Charulatha Nagar is a Neurologist practicing medicine in Glenview, Illinois. She has been practicing medicine for over 36 years. Dr. Nagar is rated as a Distinguished provider by MediFind in the treatment of Glycogen Storage Disease Type 9. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Adult Polyglucosan Body Disease, Andersen Disease, Glycogen Storage Disease Type 13, and Phosphoglycerate Mutase Deficiency. Dr. Nagar is board certified in American Board Of Psychiatry And Neurology - Neurology (Certified).

What are the latest Glycogen Storage Disease Type 9 Clinical Trials?
GSD VI and GSD IX Natural History

Summary: Collection and review of clinical information related to Glycogen Storage Disease Type VI (GSD VI) OR Glycogen Storage Disease Type IX (GSD IX) generated during clinic visits.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: August 01, 2015
Published By: National Institutes of Health